AMGN vs LXU · P/E 24, rev $10.05B vs rev $337.6M
Amgen Inc (AMGN) versus Lsb Industries Inc (LXU) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Lsb Industries Inc (LXU) is a chemicals company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported LXU revenue for 2026-06-30 was $337.6M. Net income was $13.5M. Revenue was up 99.2% from 2026-03-31 to 2026-06-30. LXU currently screens at market cap $590.8M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. LXU currently screens at market cap $590.8M.
Not investment advice. Open the AMGN and LXU stock pages for the full models.
Not investment advice.